AA
67
-5
CCL
65
-3
EQT
50
-4
EMN
62
-3
CVX
25
-4
ADI
76
-4
CI
52
3
AON
67
4
BMY
74
5
C
79
-2
CNP
52
2
AMT
37
-2
AMG
75
-7
EQIX
50
-3
APH
45
-10
EMR
65
-8
CMA
73
-4
AMZN
50
-5
EOG
49
-3
CA
21
-6
AA
67
-5
CCL
65
-3
EQT
50
-4
EMN
62
-3
CVX
25
-4
ADI
76
-4
CI
52
3
AON
67
4
BMY
74
5
C
79
-2
CNP
52
2
AMT
37
-2
AMG
75
-7
EQIX
50
-3
APH
45
-10
EMR
65
-8
CMA
73
-4
AMZN
50
-5
EOG
49
-3
CA
21
-6
Financhill
Back

Guinness Atkinson Asia Pacific Divi Builder ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
44

ADIV
Guinness Atkinson Asia Pacific Divi Builder ETF

Last Price:
$17.99
Seasonality Move:
-1.87%
Sell
34

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Sell
44
Guinness Atkinson Asia Pacific Divi Builder ETF (ADIV) is a Sell

Is Guinness Atkinson Asia Pacific Divi Builder ETF a Buy, Sell or Hold?

  • The current Guinness Atkinson Asia Pacific Divi Builder ETF [ADIV] share price is $18.01. The Score for ADIV is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ADIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADIV Stock Price Chart

What is Guinness Atkinson Asia Pacific Divi Builder ETF's stock price today?

  • The Guinness Atkinson Asia Pacific Divi Builder ETF share price today is $18.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADIV is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

ADIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39.91 Sell
Chaikin Money Flow: -1260 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.21 - 18.57) Sell
Bollinger Bands (100): (18.01 - 18.51) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

ADIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.26 Sell
20-day SMA: 18.34 Sell
50-day SMA: 18.3 Sell
200-day SMA: 17.27 Buy
8-day EMA: 18.25 Sell
20-day EMA: 18.32 Sell
50-day EMA: 18.3 Sell
200-day EMA: 17.46 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Guinness Atkinson Asia Pacific Divi Builder ETF Earnings Growth & ADIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Guinness Atkinson Asia Pacific Divi Builder ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):